2 2 MD Salisbury Ltd 11252835 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is as a holding company. Digita Accounts Production Advanced 6.30.9574.0 true 11252835 2024-07-01 2025-06-30 11252835 2025-06-30 11252835 core:CurrentFinancialInstruments 2025-06-30 11252835 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 11252835 bus:SmallEntities 2024-07-01 2025-06-30 11252835 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 11252835 bus:FilletedAccounts 2024-07-01 2025-06-30 11252835 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 11252835 bus:RegisteredOffice 2024-07-01 2025-06-30 11252835 bus:Director1 2024-07-01 2025-06-30 11252835 bus:Director2 2024-07-01 2025-06-30 11252835 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 11252835 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 11252835 bus:Agent1 2024-07-01 2025-06-30 11252835 countries:AllCountries 2024-07-01 2025-06-30 11252835 2023-07-01 2024-06-30 11252835 2024-06-30 11252835 core:CurrentFinancialInstruments 2024-06-30 11252835 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 11252835 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 xbrli:pure iso4217:GBP

Registration number: 11252835

MD Salisbury Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 June 2025

 

MD Salisbury Ltd

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3

Notes to the Unaudited Financial Statements

4 to 6

 

MD Salisbury Ltd

Company Information

Directors

Mr Mark Hunter Dobson

Mrs Danielle Dobson

Registered office



Registered number

106 Bouverie Avenue South
Salisbury
SP2 8DZ

11252835
 

Accountants

Brown, Scott & Main
Chartered Accountants91 West Savile Terrace
Edinburgh
EH9 3DP

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
MD Salisbury Ltd
for the Year Ended 30 June 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of MD Salisbury Ltd for the year ended 30 June 2025 as set out on pages 3 to 6 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of The Institute of Chartered Accountants of Scotland, we are subject to its ethical and other professional requirements which are detailed at www.icas.com/accountspreparationguidance

This report is made solely to you, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the financial information of MD Salisbury Ltd and state those matters that we have agreed to state to you in this report in accordance with the requirements of The Institute of Chartered Accountants of Scotland as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company for our work or for this report.

It is your duty to ensure that MD Salisbury Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of MD Salisbury Ltd. You consider that MD Salisbury Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of MD Salisbury Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Brown, Scott & Main
Chartered Accountants
91 West Savile Terrace
Edinburgh
EH9 3DP

17 December 2025

 

MD Salisbury Ltd

(Registration number: 11252835)
Balance Sheet as at 30 June 2025

Note

2025
£

2024
£

Current assets

 

Debtors

5

-

175,000

Cash at bank and in hand

 

813,796

887,407

 

813,796

1,062,407

Creditors: Amounts falling due within one year

6

(2,100)

(273,106)

Net assets

 

811,696

789,301

Capital and reserves

 

Called up share capital

7

2

2

Retained earnings

811,694

789,299

Shareholders' funds

 

811,696

789,301

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 17 December 2025 and signed on its behalf by:
 

.........................................
Mr Mark Hunter Dobson
Director

 

MD Salisbury Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office and principal place of business is:
106 Bouverie Avenue South
Salisbury
SP2 8DZ

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention.

The presentation currency is sterling.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities.

The company recognises revenue when: the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises corporation tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Impairment of assets

At each reporting date fixed asset investments are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in profit or loss.

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

MD Salisbury Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

4

Taxation

The tax (credit) / charge on the profit for the year was as follows:

2025

2024

£

£

UK corporation tax

-

-

5

Debtors

2025
£

2024
£

Other debtors

-

175,000

-

175,000

 

MD Salisbury Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

6

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Accruals and deferred income

2,100

15,300

Other creditors

-

257,806

2,100

273,106

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

2

2

2

2

       

8

Dividends

Interim dividends paid

2025
£

2024
£

Interim dividend of £Nil per each Ordinary £1 share

-

-